A61K8/41

POLYMERIC FATTY ACID SALT COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID-BASED SUBSTRATES, ESPECIALLY HAIR

The present invention is directed at organic ammonium salts comprising

an organic ammonium-group-comprising cation which does not contain an estolide moiety and a carboxylate anion (COO—) group-comprising anion selected from the group consisting of anions containing at least one estolide moiety or carboxylate anions containing at least one internal ester group.

The invention is also directed at a process for the production of such organic ammonium salts, the use of such organic ammonium salts in cosmetic formulations for skin and hair care, the use of such organic ammonium salts for the treatment of fibers, the use of the organic ammonium salts for the treatment of hair, at compositions containing such organic ammonium salts, the use of the products of the process for the production of organic ammonium salts in cosmetic formulations for skin care and hair conditioner and hair shampoo, the use of said products for the treatment of fibers, and compositions containing said products for the treatment of hair.

COMPOSITIONS CONTAINING DIRECT DYES FOR IMPARTING COLOR AND TONE TO THE HAIR
20230025989 · 2023-01-26 ·

The present disclosure relates to compositions for altering the tone or color of the hair, the compositions comprising at least one amino acid, at least one carboxylic acid, monoethanolamine, and at least one hair coloring agent comprising a direct dye. The disclosure also relates to methods of using the compositions.

COMPOSITIONS CONTAINING DIRECT DYES FOR IMPARTING COLOR AND TONE TO THE HAIR
20230025989 · 2023-01-26 ·

The present disclosure relates to compositions for altering the tone or color of the hair, the compositions comprising at least one amino acid, at least one carboxylic acid, monoethanolamine, and at least one hair coloring agent comprising a direct dye. The disclosure also relates to methods of using the compositions.

HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION

A conditioning composition results in improved particulate benefit agent deposition on to hair, said composition comprising: (i) 0.01 to 10 wt % of a linear cationic conditioning primary surfactant; selected from structure 1 and mixtures thereof; (ii) 0.1 to 10 wt % of a linear fatty material; (iii) a particulate benefit agent selected from conditioning actives and mixtures thereof; (iv) 0.01 to 5 wt % of a linear di-alkyl cationic co-surfactant, selected from structure 2 and mixtures thereof.

##STR00001##

HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION

A composition provides superior deposition of benefit agent to hair, said composition comprising: (i) 0.01 to 10 wt % of a linear cationic conditioning primary surfactant; selected from structure 1 and mixtures thereof: Structure 1 wherein: R1 comprises a linear alkyl chain having a carbon-carbon chain length of from C16 to C24, preferably C18 to C22; 10. R2 comprises a proton or a linear alkyl chain having a carbon-carbon chain length of from C1 to C4, preferably C1 to C2 or a benzyl group; and X is an organic or inorganic anion; (ii) 0.1 to 10 wt % of a linear fatty material; 15 (iii) a particulate benefit agent selected from conditioning actives and mixtures thereof; (iv) 0.01 to 5 wt %, of a linear cationic co-surfactant, selected from structure 2 and mixtures thereof wherein: R2 comprises a proton or a linear alkyl chain having a carbon-carbon chain length of from C1 to C4, preferably C1 to C2 or a benzyl group; R3 comprises a linear alkyl chain having an atom-atom chain length of from 3 to 15, 25 preferably 10 to 14; and #X is an organic or inorganic anion; J30413EP CPL—24—wherein the carbon-carbon chain length of R1 in structure 1 differs from the atom-atom chain length of R3 in structure 2 by at least 3 atoms, such that the carbon-carbon chain length of R1 is structure 1 is longer than the atom-atom chain length of R3 in structure 2; and wherein the molar ratio of linear cationic co-surfactant (iv) to linear cationic conditioning primary surfactant (i) is in the range of from 1:20 to 1:1.

##STR00001##

Hair strengthening ingredient and method for strengthening hair

A method for strengthening and repairing keratin fibres including providing a first—and a second crosslinking composition, wherein the first—crosslinking composition comprises an at least bi-functional Brønsted-base and the second—crosslinking composition comprises—an at least bi-functional organic acid, and a cosmetically acceptable carrier; applying the first—as well as the second—crosslinking composition to keratin fibres; and optionally mixing the first—crosslinking composition into a commercially available hair coloring or hair bleaching composition.

Hair strengthening ingredient and method for strengthening hair

A method for strengthening and repairing keratin fibres including providing a first—and a second crosslinking composition, wherein the first—crosslinking composition comprises an at least bi-functional Brønsted-base and the second—crosslinking composition comprises—an at least bi-functional organic acid, and a cosmetically acceptable carrier; applying the first—as well as the second—crosslinking composition to keratin fibres; and optionally mixing the first—crosslinking composition into a commercially available hair coloring or hair bleaching composition.

Toxic aldehyde related diseases and treatment

The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.

Toxic aldehyde related diseases and treatment

The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.

Rheofluidifying concentrated foaming composition and uses of same, in particular for body hygiene

A rheofluidifying surfactant composition structured into planar lamellar phases includes: a) at least one anionic surfactant and b) at least one compound selected from among amphoteric surfactants and non-ionic surfactants, in which the total active material of said surfactants is between 35 and 60% by weight relative to the total weight of said composition, in which the ratio of anionic surfactant is between 0.3 and 0.9, the ratio of amphoteric surfactant is between 0.0 and 0.7 and the ratio of non-ionic surfactant is between 0.0 and 0.7, said ratio being the ratio between the weight percentage of active material of said surfactant in said composition and the weight percentage of total active material of said surfactants in said composition, the pH of the composition being between 4 and 8, said at least one anionic surfactant being selected from the group comprising alkyl sulfates, alkyl ether sulfates, sulfonates, derivatives of phosphoric acid, phosphates and alkyl phosphates, isethionates, taurates, sulfoccinates, alkyl sulfoacetates, anionic derivatives of proteins of plant origin, amino acids and amino acid derivatives, polypeptides, carboxylic acids and the salts of same, salts of fatty acids from saponification, lactic acid derivatives and alkyl polyglucoside derivatives, and said composition being free of sodium chloride other than that which may be provided by the surfactants.